UCB SA (UNC)
FSX
Real-time Data
06:00 AM
Day's Range
221.0052 wk Range
194.40Overview - UNC - UCB SA
Key Statistics
Valuation
Enterprise Value
44.38B
P/E (Trailing)
‪19.27‬
Price / Sales (TTM)
‪4.87‬
Price / Book
‪3.81‬
EV / EBITDA
‪13.28‬
Profitability
Profit Margin
‪25.73%‬
Operating Margin
‪33.32%‬
Return on Assets
‪8.97%‬
Return on Equity
‪20.56%‬
Ownership
Shares Outstanding
190.66M
Float
120.15M
Held by Insiders
‪36.27%‬
Held by Institutions
‪38.55%‬
Price stats
Beta
‪0.18‬
50-Day Avg
‪239.84‬
200-Day Avg
‪247.78‬
Dividends
Payout Ratio
‪12.81%‬
Frequency
Annual
Peers - UNC - UCB SA
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- UNCFSXUCB SA41.56BMarket Cap+11.06%52-week change19.27P/E (Trailing)‪25.73%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - UNC - UCB SA
About
UCB SA is a multinational biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928 by Emmanuel Janssen. It specializes in developing innovative medicines for severe neurological and immunological diseases, including epilepsy, Parkinson's disease, Crohn's disease, psoriasis, and autoimmune…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
